A synthetic peptide for use as a blocking control in assays to test for specificity of MAGEA3 antibody, Alternative Names: MAGEA3 control peptide, MAGEA3 antibody Blocking Peptide, Anti-MAGEA3 Blocking Peptide, Melanoma Antigen Family A 3 Blocking Peptide, HIP8 Blocking Peptide, HYPD Blocking Peptide, MAGE3 Blocking Peptide, MAGEA6 Blocking Peptide, MGC14613 Blocking Peptide, MAGEA3, MAGEA-3, MAGEA 3, MAGEA-3 Blocking Peptide, MAGEA 3 Blocking Peptide
MAGEA3
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MAGEA3
(Melanoma Antigen Family A, 3 (MAGEA3))
Hintergrund
MAGEA3 is a member of the MAGEA family. The members of this family have 50 to 80 % sequence identity to each other. The promoters and first exons of the MAGEA genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. The MAGEA genes are clustered at chromosomal location Xq28. They have been implicated in some hereditary disorders, such as dyskeratosis congenita.